The Prognosis of Single Hormone Receptor-Positive Breast Cancer Stratified by HER2 Status

Single estrogen receptor (ER)+ and progesterone receptor (PR)+ tumors account for about10% of all breast cancers. However, the prognosis of these single hormone receptor-positive (HR+) tumor remains unclear. We aimed to investigate the characteristics of single HR+ breast tumors according to HER2 st...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Hengqiang, Gong, Yiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165305/
https://www.ncbi.nlm.nih.gov/pubmed/34079755
http://dx.doi.org/10.3389/fonc.2021.643956

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165305/
https://www.ncbi.nlm.nih.gov/pubmed/34079755
http://dx.doi.org/10.3389/fonc.2021.643956

Ejemplares similares